Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$1.72 - $4.47 $101,798 - $264,556
-59,185 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$2.6 - $4.7 $121,521 - $219,673
-46,739 Reduced 44.13%
59,185 $266,000
Q2 2019

Aug 14, 2019

BUY
$2.58 - $5.31 $273,283 - $562,456
105,924 New
105,924 $286,000

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $110M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.